Trends in Low-Density Lipoprotein Cholesterol Goal Achievement in High Risk United States Adults: Longitudinal Findings from the 1999–2008 National Health and Nutrition Examination Surveys-Reference-Cited by-同舟云学术

Trends in Low-Density Lipoprotein Cholesterol Goal Achievement in High Risk United States Adults: Longitudinal Findings from the 1999–2008 National Health and Nutrition Examination Surveys

Published:2013-04-02 Issue:4 Volume:8 Page:e59309
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tattersall Matthew C.,Gangnon Ronald E.,Karmali Kunal N.,Cullen Michael W.,Stein James H.,Keevil Jon G.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III);Panel NCEP Expert;JAMA,2001

2. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease;MH Frick;N Engl J Med,1987

3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

4. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial;SJ Robins;JAMA,2001

5. Intima-media thickness: a tool for atherosclerosis imaging and event prediction;DH O’Leary;Am J Cardiol,2002

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in low-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study;PLOS ONE;2023-05-31

2. Effects on hepatic lipid metabolism in human hepatoma cells following overexpression of TGFβ induced factor homeobox 1 or 2;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2019-05

3. Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high-dose statin;Cardiovascular Therapeutics;2017-11-25

4. Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition with Bococizumab on Lipoprotein Particles in Hypercholesterolemic Subjects;Clinical Therapeutics;2017-11

5. Clinical and economic consequences of statin intolerance in the United States: Results from an integrated health system;Journal of Clinical Lipidology;2017-01